Novel inhaled combination powders for respiratory infections

• In: APSA EARLY CAREER RESEARCHER SYMPOSIUM on Tuesday, 15 April 2014, 16:00-17:30
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: ZHOU, Qi (Tony) (The University of Sydney, Faculty of Pharmacy, Sydney, Australia)
• Co-author(s): Gengenbach, Thomas (CSIRO Materials Science and Engineering, Melbourne, Australia)
  Denman, John (University of South Australia, Adelaide, Australia)
  Yu, Heidi (Monash University, Melbourne, Australia)
  Li, Jian (Monash University, Melbourne, Australia)
  Chan, Hak-Kim (The University of Sydney, Sydney, Australia)
  
• Abstract:

  Background: For many respiratory infections caused by multidrug-resistant Gram-negative bacteria, colistin is the only effective antibiotics despite its nephrotoxicity. Inhaled therapy of colistin with a synergistic antimicrobial component of rifampicin may offer better therapeutic efficacy and reduce adverse effects.
  Aims: To develop a novel..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login